Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 16Sarcoma 4Head & Neck 3Gastrointestinal 3Breast 3Thoracic 2Genitourinary 2Dermatologic 2Plasma cell 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Lung Neoplasms 102Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 16Neoplasm Metastasis 14Melanoma 14Brain Neoplasms 14Small Cell Lung Carcinoma 13Esophageal Neoplasms 10Colorectal Neoplasms 9Carcinoma, Renal Cell 9Pancreatic Neoplasms 8Ovarian Neoplasms 8Adenocarcinoma of Lung 8Prostatic Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Stomach Neoplasms 5Carcinoma, Transitional Cell 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Sarcoma, Kaposi 4Rectal Neoplasms 4Meningeal Carcinomatosis 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3HIV Infections 3Carcinoma, Medullary 3

Interventions

pembrolizumab 30Carboplatin 13Trastuzumab 8Paclitaxel 7Nivolumab 7Cisplatin 6Ipilimumab 5Cetuximab 5Bevacizumab 5Taxes 4Pemetrexed 4Specimen Handling 3Irinotecan 3Docetaxel 3Cyclophosphamide 3Biopsy 3tisotumab vedotin 2temsirolimus 2spartalizumab 2sargramostim 2pertuzumab 2lenvatinib 2fludarabine 2epacadostat 2enzalutamide 2aldesleukin 2X-Rays 2Ritonavir 2Psychiatric Rehabilitation 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Magnetic Resonance Spectroscopy × Thoracic × Clear all
NCT02465060 2026-06-03

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
6,452 enrolled 1 FDA
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT05269381 2026-03-12

PNeoVCA

Mayo Clinic

Phase 1/2 Recruiting
132 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡